Benzinga | May 4, 2021 08:18AM EDT

Kiniksa Pharmaceuticals Q1 EPS $(0.72) Down From $(0.48) YoY

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.72) per share. This is a 50 percent decrease over losses of $(0.48) per share from the same period last year.